Seven out of ten melanomas have alterations in the MAPK pathway, including point mutations/SCNAs in BRAF and NF1, and mutations in KRAS and ARAF. Melanoma with BRAF D594N substitution had also a mutation in KRAS (A146T) and one in ARAF (P194A/Q). This evidence concerns the gene ARAF and melanoma.